A European specialty pharmaceutical company with no U.S. infrastructure faced a highly competitive market for the launch of its new product. Launching into a well established market meant an uphill battle for market share. The company needed market insight and access to key commercial insurance decision-makers. 

Learn how Quintiles helped gain significant market penetration, representing more than 190 million covered lives within one year.